Cargando…
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
PURPOSE OF REVIEW: Over the last years, targeted anticancer therapy with small molecule inhibitors and antibodies has much replaced chemoimmunotherapy, which has been the gold standard of care for patients with chronic lymphocytic leukemia (CLL). Here we give an overview of novel targeted agents use...
Autores principales: | Scheffold, Annika, Stilgenbauer, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002327/ https://www.ncbi.nlm.nih.gov/pubmed/32025827 http://dx.doi.org/10.1007/s11912-020-0881-4 |
Ejemplares similares
-
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies
por: Rivera, Daniel, et al.
Publicado: (2022) -
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic
por: Arellano-Llamas, Abril Adriana, et al.
Publicado: (2022) -
Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission
por: Stuckey, Ruth, et al.
Publicado: (2022) -
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
por: Milne, Kate, et al.
Publicado: (2020) -
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
por: Meillon-Garcia, Luis Antonio, et al.
Publicado: (2020)